Cargando…
口服长春瑞滨节拍化疗治疗晚期多线治疗失败的非小细胞肺癌的临床观察
BACKGROUND AND OBJECTIVE: The development of new treatments beyond first-line in metastatic non-small cell lung cancer (NSCLC) contributed to the increase in overall survival. Metronomic chemotherapy involves several mechanisms of anti-tumor with less toxicity. Oral vinorelbine has paved the way for...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973282/ https://www.ncbi.nlm.nih.gov/pubmed/29167002 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.11.03 |
Ejemplares similares
-
长春瑞滨联合奥沙利铂对比长春瑞滨联合顺铂治疗中晚期非小细胞肺癌的系统评价
Publicado: (2010) -
长春瑞滨联合异环磷酰胺三线以后治疗晚期非小细胞肺癌的疗效和不良反应
Publicado: (2015) -
节拍化疗——晚期非小细胞肺癌另辟蹊径的治疗策略
Publicado: (2015) -
吉西他滨联合长春瑞滨方案一线治疗中国晚期非小细胞肺癌患者的多中心回顾性研究
Publicado: (2012) -
铂类联合多西他赛或长春瑞滨一线治疗晚期非小细胞肺癌的meta分析
Publicado: (2014)